Hana Biosciences
About Us
Investor Relations
Press Releases
Events & Webcasts
Presentations & Publications
Corporate Governance
Financial Information
Stock Information
Contact Us
Shareholder Tools
Briefcase Shareholder Briefcase
Printed Materials Printed Materials
Email Alerts Email Alerts
Download Center Download Library
RSS RSS News Feeds
Search Investor Relations


Investor Relations

Hana Biosciences, Inc. is a South San Francisco, CA-based biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to strengthen the foundation of cancer care. The company is committed to creating value by building a best in-class team, accelerating the development of lead product candidates, expanding its pipeline by being the alliance partner of choice, and nurturing a unique company culture.

OTCBB: HNAB.OB
Last Price $0.19  
Change + 0.01 2.70%
Volume 5,800
Last Trade Mar 11, 2010
10:01 AM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.

Recent Releases

Mar 11, 2010
Hana Biosciences Appoints Craig W. Carlson as Chief Financial Officer

Feb 1, 2010
Hana Biosciences to Present at the 12th Annual BIO CEO & Investor Conference

View all releases »